A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Cancer
Lung Cancer
Small Cell Lung Carcinoma
Small Cell Lung Cancer

Results
Download
Print

Study results

LPS GO30081 IMpower133 Final Results January 2021 English (PDF, 0.4 MB)

LPS GO30081 IMpower133 Final Results January 2021 German (PDF, 0.3 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Study results

LPS GO30081 IMpower133 Final Results January 2021 English (PDF, 0.4 MB)

LPS GO30081 IMpower133 Final Results January 2021 German (PDF, 0.3 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

For the latest version of this information please go to www.forpatients.roche.com